Cimeio Therapeutics AG
Pharmaceuticals · Basel, Basel-Stadt
Cimeio Therapeutics AG is a Swiss pharmaceuticals company based in Basel, Canton of Basel-Stadt, listed in the Swiss commercial register since 2020 (UID CHE-465.367.689).
Board members & signatories
- Alexander Mayweg — Präsident des Verwaltungsrates
- Markus Enzelberger — Mitglied des Verwaltungsrates
- Josef Jeker — Mitglied des Verwaltungsrates
Registered purpose
Die Gesellschaft bezweckt die Entwicklung, die Produktion und den Vertrieb von pharmazeutischen und immunopharmazeutischen Produkten sowie die Erbringung damit im Zusammenhang stehenden Dienstleistungen. Die Gesellschaft kann sich daneben an anderen Unternehmen irgendwelcher Art im In- und Ausland beteiligen, solche gründen, übernehmen und mit ihnen fusionieren. Sie kann Liegenschaften und Immater…
Source: Swiss commercial register (Zefix / SOGC) and Alpintel analysis · Data as of March 2026
What Cimeio Therapeutics does
OFFERING
Cimeio Therapeutics develops Shielded-Cell & Immunotherapy Pairs™ (SCIP), which are novel immunotherapies aimed at treating hematologic diseases. The company focuses on creating modified variants of naturally occurring cell surface proteins in hematopoietic stem cells (HSCs) that are resistant to depletion by paired immunotherapies, which have a high affinity for the wild-type proteins.
Unlock the full analysis →Similar companies
- ICE Biopharma GmbH — Pharmaceuticals · Zug
- ImmunOs Therapeutics AG — Pharmaceuticals · Schlieren
- T3 Pharmaceuticals AG — Pharmaceuticals · Allschwil
- Metys Pharmaceuticals AG — Pharmaceuticals · Basel
- EsoCap AG — Pharmaceuticals · Basel
- Biogen International GmbH — Biotechnology · Baar
Find every pharmaceuticals company in Switzerland
Alpintel searches all 710,000 Swiss companies with AI — filter by industry, size, revenue, region and ownership in seconds.
family-owned pharmaceuticals companies with 50+ employees…Search →Full profiles from CHF 49/month · Cancel anytime